Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Stevanato Group S.P.A. (STVN)

Stevanato Group S.P.A. (STVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,792,585
  • Shares Outstanding, K 295,540
  • Annual Sales, $ 1,175 M
  • Annual Income, $ 157,620 K
  • 60-Month Beta 0.58
  • Price/Sales 4.43
  • Price/Cash Flow 23.18
  • Price/Book 4.77
Trade STVN with:

Options Overview Details

View History
  • Implied Volatility 45.39% ( -17.40%)
  • Historical Volatility 53.83%
  • IV Percentile 18%
  • IV Rank 44.83%
  • IV High 82.03% on 11/02/23
  • IV Low 15.62% on 06/13/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 6
  • Put/Call OI Ratio 5.71
  • Today's Open Interest 141
  • Open Int (30-Day) 141

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.10
  • Number of Estimates 4
  • High Estimate 0.11
  • Low Estimate 0.10
  • Prior Year 0.15
  • Growth Rate Est. (year over year) -33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.85 +16.32%
on 06/27/24
22.83 -14.15%
on 07/12/24
+2.44 (+14.22%)
since 06/26/24
3-Month
16.56 +18.36%
on 06/25/24
28.77 -31.87%
on 05/01/24
-7.94 (-28.83%)
since 04/26/24
52-Week
16.56 +18.36%
on 06/25/24
36.30 -46.01%
on 08/09/23
-12.71 (-39.34%)
since 07/26/23

Most Recent Stories

More News
Global Medical Device Packaging Market Size Expected to Reach $50 Billion By 2028

EQNX::TICKER_START (NASDAQ:STSS),(NYSE:STVN),(NYSE:WST),(NYSE:BDX),(NYSE:PFE) EQNX::TICKER_END

STSS : 0.2896 (-1.83%)
STVN : 19.60 (-0.96%)
WST : 284.76 (+2.74%)
BDX : 237.30 (+1.94%)
PFE : 30.77 (+3.39%)
Stevanato Group Reports First Quarter 2023 Financial Results

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced...

STVN : 19.60 (-0.96%)
Stevanato Group to Present at BofA Securities Healthcare Conference

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...

STVN : 19.60 (-0.96%)
Stevanato Group to Report First Quarter 2023 Financial Results on May 4, 2023

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...

STVN : 19.60 (-0.96%)
Stevanato Group Collaborates with Thermo Fisher Scientific to Bring its Innovative On-Body Delivery System Platform to Market

Stevanato Group S.p.A. (NYSE: STVN) a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today its collaboration...

STVN : 19.60 (-0.96%)
Stevanato Group Collaborates with Recipharm to Develop and Manufacture Pre-fillable Syringes for Use in a New Soft Mist Inhaler for the Inhalation of Sensitive Biological Products

Stevanato Group S.p.A. (NYSE: STVN) a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced...

STVN : 19.60 (-0.96%)
Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...

STVN : 19.60 (-0.96%)
Stevanato Group Secures €130 Million ESG-Linked Financing From BNL BNP Paribas and Cassa Depositi e Prestiti to Support Sustainable Global Growth

Stevanato Group S.p.A. (NYSE: STVN), a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced two...

STVN : 19.60 (-0.96%)
Stevanato Group Reports Fourth Quarter and Fiscal Year 2022 Financial Results

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced...

STVN : 19.60 (-0.96%)
Stevanato Group to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 2, 2023

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...

STVN : 19.60 (-0.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Stevanato Group S.p.A. is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. Stevanato Group S.p.A. is based in PIOMBINO DESE, Italy.

See More

Key Turning Points

3rd Resistance Point 21.21
2nd Resistance Point 20.83
1st Resistance Point 20.21
Last Price 19.60
1st Support Level 19.21
2nd Support Level 18.83
3rd Support Level 18.21

See More

52-Week High 36.30
Fibonacci 61.8% 28.76
Fibonacci 50% 26.43
Fibonacci 38.2% 24.10
Last Price 19.60
52-Week Low 16.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar